Characterization of a Novel PERK Kinase Inhibitor with Antitumor and Antiangiogenic Activity
Year: 2013
Type: article
Source: Cancer Research
Institution: GlaxoSmithKline (United States)
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W1991250346
